Genprex, Inc. (GNPX)
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Genprex, Inc.
NASDAQ:GNPXHealthcare · Biotechnology
+9.80%$2.24
AH$2.30+2.68%vs close
Mkt Cap$1.84M
Float817K
O/S820K
Vol
$ Vol
RVOL
Inst Own1.7%
SI15.3%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$16.23M
Total Assets$10.16M
Free Cash Flow-$15.31M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$7.96M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:1,100Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:22Reverse splitJul 16, 202622 shares → 1
- 1:50Reverse splitOct 21, 202550 shares → 1
- 1:40Reverse splitFeb 2, 202440 shares → 1
Balance Sheet Details
Assets$10.16M
Liabilities$2.2M
Accounts Receivable$0
Accounts Payable$743K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $7K | $15K | $26K | $23K | $23K | $13K | $6K | $0 | $0 | $0 |
| Gross Profit | $0 | -$7K | -$15K | -$26K | -$23K | -$23K | -$13K | -$6K | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $9.43M | $10.54M | $17.62M | $11.51M | $8.97M | $7.3M | $1.97M | $971K | $290K | $355K | $202K |
| Selling, General, and Administrative | $6.09M | $10.63M | $13.44M | $12.3M | $11.68M | $10.64M | $8.7M | $11.39M | $3.02M | $3.78M | $866K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6K | $3K | $0 | $0 |
| Total Operating Expenses | $15.52M | $21.17M | $31.06M | $23.81M | $20.65M | $17.94M | $10.67M | $12.36M | $3.31M | $4.13M | $1.07M |
| Operating Income (EBIT) | -$15.52M | -$21.17M | -$31.08M | -$23.83M | -$20.67M | -$17.96M | -$10.68M | -$12.36M | -$3.31M | -$4.13M | -$1.07M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $740K | $0 | $0 | $0 | $0 | $0 | $0 | $38K | $2K | $0 | $0 |
| Interest Income | $0 | $64K | $215K | $90K | $5K | $19K | $28K | $29K | $80 | $0 | $0 |
| Other Income (Expense) | -$713K | $63K | $215K | $90K | $5K | $19K | $28K | -$9K | -$2K | $0 | $0 |
| Income Before Tax (EBT) | -$16.23M | -$21.11M | -$30.86M | -$23.74M | -$20.66M | -$17.94M | -$10.65M | -$12.37M | -$3.31M | -$4.13M | -$1.07M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $29K | $80 | $0 | $0 |
| Net Income | -$16.23M | -$21.11M | -$30.86M | -$23.74M | -$20.66M | -$17.94M | -$10.65M | -$12.37M | -$3.31M | -$4.13M | -$1.07M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -382.80 | -5872.98 | -24838.00 | -21780.00 | -19305.00 | -22198.00 | -29304.00 | -39567.00 | -12705.00 | -16830.00 | -25575.00 |
| Diluted EPS | -382.80 | -5872.98 | -24816.00 | -21780.00 | -19305.00 | -22198.00 | -29249.00 | -39534.00 | -12683.00 | -16786.00 | -25223.00 |
| Weighted Average OS | 42,397 | 3,642 | 1,243 | 1,089 | 1,070 | 807 | 364 | 313 | 261 | 245 | 42 |
| EBITDA | -$15.49M | -$21.1M | -$30.85M | -$23.72M | -$20.64M | -$17.92M | -$10.64M | -$12.33M | -$3.31M | -$4.13M | -$1.07M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $7.83M | $1.6M | $6.74M | $20.95M | $38.63M | $27.32M | $2M | $8.6M | $161K | $1.6M | $234K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $7.83M | $1.6M | $6.74M | $20.95M | $38.63M | $27.32M | $2M | $8.6M | $161K | $1.6M | $234K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $127 | $655 | $9K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $3.01M | $802K | $0 | $0 | $0 | $0 |
| Other Current Assets | $526K | $476K | $794K | $35K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $8.36M | $2.08M | $7.53M | $21.47M | $39.14M | $30.72M | $2.98M | $8.85M | $194K | $1.64M | $250K |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $0 | $0 | $8K | $23K | $49K | $39K | $45K | $24K | $8K | $5K | $1K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $773K | $702K | $642K | $602K | $491K | $379K | $299K | $241K | $156K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.8M | $2.05M | $2.36M | $2.89M | $3.03M | $11K | $22K | $18K | $760K | $26K | $3K |
| Total Long-Term Assets | $1.8M | $2.05M | $3.14M | $3.61M | $3.72M | $652K | $558K | $422K | $1.07M | $272K | $160K |
| Other Assets | $1 | $1 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $10.16M | $4.12M | $10.67M | $25.09M | $42.86M | $31.37M | $3.53M | $9.27M | $1.26M | $1.91M | $410K |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $743K | $1.07M | $1.4M | $443K | $973K | $193K | $436K | $295K | $629K | $110K | $16K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.43M | $1.43M | $1.86M | $2.37M | $612K | $258K | $74K | $93K | $202K | $36K | $0 |
| Total Current Liabilities | $2.17M | $2.5M | $3.25M | $2.81M | $1.59M | $451K | $511K | $388K | $831K | $286K | $16K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $23K | $0 | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $23K | $0 | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.2M | $2.5M | $3.25M | $2.81M | $1.59M | $451K | $511K | $388K | $831K | $286K | $16K |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1K | $1K |
| Common Stock | $3K | $11K | $1K | $1K | $48K | $43K | $19K | $15K | $12K | $328 | $308 |
| Retained Earnings | -$171.03M | -$154.8M | -$133.69M | -$102.83M | -$79.09M | -$58.42M | -$40.48M | -$29.82M | -$17.45M | -$14.14M | -$10.01M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $178.99M | $156.41M | $141.1M | $125.1M | $120.32M | $89.3M | $43.48M | $38.69M | $17.87M | $15.76M | $10.4M |
| Total Equity | $7.96M | $1.62M | $7.42M | $22.27M | $41.28M | $30.92M | $3.02M | $8.88M | $429K | $1.62M | $394K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $10.16M | $4.12M | $10.67M | $25.09M | $42.86M | $31.37M | $3.53M | $9.27M | $1.26M | $1.91M | $410K |
| Supplementary Data | |||||||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $93K | $202K | $0 | $0 |
| Net Debt | -$7.83M | -$1.6M | -$6.74M | -$20.95M | -$38.63M | -$27.32M | -$2M | -$8.51M | $41K | -$1.6M | -$234K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$16.23M | -$21.11M | -$30.86M | -$23.74M | -$19.59M | -$17.94M | -$10.65M | -$12.37M | -$3.31M | -$4.13M | -$1.07M |
| Depreciation & Amortization | $0 | $7K | $15K | $26K | $23K | $23K | $13K | $6K | $3K | $862 | $2K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | -$4.61M | -$4.54M | -$3.41M | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $313K | $3.3M | $5.41M | $4.73M | $5.35M | $4.25M | $3.53M | $5.44M | $1.32M | $2.66M | $441K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $35K | -$35K | $127 | $528 | $9K | -$453 | -$663 | -$1 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $47K | -$231K | $0 | $0 | $0 |
| Accounts Payable | -$331K | -$323K | $955K | -$530K | $780K | -$247K | $141K | -$443K | $0 | $0 | $0 |
| Other Working Capital | $196K | $202K | -$291K | $1.77M | $230K | -$15K | -$4K | $760K | -$184K | $226K | -$62K |
| Total Working Capital Change | -$135K | -$121K | $698K | $1.2M | $1.01M | -$261K | $193K | $85K | -$185K | $226K | -$62K |
| Other Non-Cash Items | $740K | $773K | $0 | $0 | $3.54M | $4.54M | $3.41M | $5.45M | $545 | $269 | -$59 |
| Net Cash from Operating | -$15.31M | -$17.15M | -$24.74M | -$17.78M | -$14.28M | -$13.94M | -$6.92M | -$6.85M | -$2.17M | -$1.25M | -$688K |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | $0 | -$71K | -$60K | -$84K | -$2.34M | -$947K | -$103K | -$63K | -$90K | -$21K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $1K | $169 | $157K | $0 | $0 | $0 | -$81 | -$58 | -$85 | -$20 |
| Net Cash from Investing | $0 | $1K | -$71K | $98K | -$84K | -$2.34M | -$947K | -$103K | -$63K | -$90K | -$21K |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $21.54M | $12.01M | $10.59M | $6K | $25.68M | $41.59M | $1.27M | $15.39M | $794K | $2.71M | $200K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$277.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $277.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$2.71M | $725K |
| Net Cash from Financing | $21.54M | $12.01M | $10.59M | $6K | $25.68M | $41.59M | $1.27M | $15.39M | $794K | $2.71M | $725K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $6.23M | -$5.14M | -$14.22M | -$17.67M | $11.31M | $25.32M | -$6.6M | $8.44M | -$1.44M | $1.37M | $15K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$15.31M | -$17.15M | -$24.74M | -$17.78M | -$14.28M | -$13.94M | -$6.92M | -$6.85M | -$2.17M | -$1.25M | -$688K |
| Capital Expenditure | -$1 | $0 | -$71K | $4 | -$84K | -$2.34M | -$947K | -$103K | -$63K | -$90K | -$21K |
| Free Cash Flow | -$15.31M | -$17.15M | -$24.81M | -$17.78M | -$14.37M | -$16.27M | -$7.87M | -$6.95M | -$2.24M | -$1.34M | -$710K |
| Cash at Beginning | $1.6M | $6.74M | $20.95M | $38.63M | $27.32M | $2M | $8.6M | $161K | $1.6M | $234K | $219K |
| Cash at End | $7.83M | $1.6M | $6.74M | $20.95M | $38.63M | $27.32M | $2M | $8.6M | $161K | $1.6M | $234K |